Abstract

2055 Background: Previous studies showed that FT may be useful as treatment in recurrent high-grade glioma (HGG). The present study evaluate the activity and toxicity of FT in recurrent malignant g...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
Congxiao Wang ... Ying Luan
BMC Cancer | VOL. 20
Congxiao Wang, et. al.Congxiao Wang ... Ying Luan
24 Jun 2020
Evaluation of toxicity of carmustine with or without bevacizumab in patients with recurrent or progressive high grade gliomas.
Prakirthi Yerram ... Samantha N Reiss
Journal of Neuro-Oncology | VOL. 145
Prakirthi Yerram, et. al.Prakirthi Yerram ... Samantha N Reiss
20 Aug 2019
Oral topotecan in children with recurrent or progressive high-grade glioma: a Phase I/II study by the German Society for Pediatric Oncology and Hematology.
Sabine Wagner ... Michael Albani
Cancer | VOL. 100
Sabine Wagner, et. al.Sabine Wagner ... Michael Albani
11 Mar 2004
GEINOFOTE: efficacy and safety of fotemustine in patients with high-grade recurrent gliomas and poor performance status.
P Pérez-Segura ... M Covela
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | VOL. 18
P Pérez-Segura, et. al.P Pérez-Segura ... M Covela
05 Nov 2015
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Leptomeningeal Metastasis in the Era of CNS-Penetrant Tyrosine Kinase Inhibitor Therapy.
Mark Y Jeng ... Helena A Yu
Journal of Clinical Oncology | VOL. 42
Mark Y Jeng, et. al.Mark Y Jeng ... Helena A Yu
10 Aug 2024
Management of Locally Advanced Rectal Cancer: ASCO Guideline.
Aaron J Scott ... Sepideh Gholami
Journal of Clinical Oncology | VOL. -
Aaron J Scott, et. al.Aaron J Scott ... Sepideh Gholami
08 Aug 2024
Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201.
Jordan R Hansford ... Eric Bouffet
Journal of Clinical Oncology | VOL. -
Jordan R Hansford, et. al.Jordan R Hansford ... Eric Bouffet
07 Aug 2024
Corticosteroids for Immune-Related Adverse Events and Checkpoint Inhibitor Efficacy: Analysis of Six Clinical Trials.
Rik J Verheijden ... Karijn P M Suijkerbuijk
Journal of Clinical Oncology | VOL. -
Rik J Verheijden, et. al.Rik J Verheijden ... Karijn P M Suijkerbuijk
07 Aug 2024
View more papers